D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients.
Posted by rob on November 13, 2005 under Uncategorized | 
Be the First to Comment
Leguay T, Desplat V, Marit G, Mahon FX
Leukemia. 2005 Nov 10;
No abstract
Add A Comment
You must be logged in to post a comment.